PLRZ NASDAQ
Polyrizon Ltd.
1W: -10.8%
1M: -23.2%
3M: -36.8%
YTD: -24.6%
1Y: +46.9%
$9.61
-0.71 (-6.88%)
Weekly Expected Move ±9.4%
$8
$9
$10
$11
$11
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$10.8M
52W Range2.88-18.2
Volume56,298
Avg Volume55,732
Beta-1.34
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOTomer Izraeli
Employees6
SectorHealthcare
IndustryBiotechnology
IPO Date2024-10-29
Websitepolyrizon-biotech.com
5 Ha-Tidhar Street
Ra'anana, TA 4321545
IL
Ra'anana, TA 4321545
IL
972 9 374 0120
About Polyrizon Ltd.
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
Latest News
Polyrizon Ltd. GAAP EPS of -$0.79
Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker
Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement
Polyrizon prices $4M registered direct offering
Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Izraeli Tomer | S-Sale | 500 | $11.85 | 2026-03-31 |
| Carmel Liron | S-Sale | 942 | $12.36 | 2026-03-31 |
| Adler Oz | S-Sale | 3,292 | $12.05 | 2026-03-31 |
| Carmel Liron | S-Sale | 100 | $11.00 | 2026-03-30 |
| Izraeli Tomer | S-Sale | 3,900 | $10.90 | 2026-03-30 |